Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology
Inspira Technologies OXY B.H.N. (NASDAQ:IINN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission
Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion
Inspira Technologies OXY B.H.N. (NASDAQ:IINN) was upgraded by analysts at
Show more
Live Event:
Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team:
support@newsquantified.com